CFTR and cystic fibrosis: Researchers applied CRISPR to precisely corrected CFTR carrying homozygous F508 deletion (F508del) in exon 10 in the induced pluripotent stem cells (iPSC) separated from cystic fibrosis patients 71 and the overall correction efficiency is up to 90% using piggyBac transposase as selection marker.